Navigation Links
Lotus Pharmaceuticals, Inc. Reports Third-Quarter 2009 Results
Date:11/16/2009

BEIJING, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic of China, today reported third-quarter 2009 net earnings were $5.4 million, or $0.11 per diluted share, compared with $3.2 million, or $0.07 per diluted share, in 2008. Net revenues were $14.5 million during the third quarter of 2009, compared with $16.7 million in the third quarter of 2008.

The third quarter was highlighted by continued strong performance in the Company's wholesale business. Profitability increased due to increased sales demand and successful cost-reduction actions.

    Third-Quarter 2009 Results
    -- Earnings Before Interest and Taxes (EBIT) for the third quarter ended
       September 30, 2009, were $6.0 million, compared with EBIT of $3.7
       million during the same period in 2008.
    -- EBIT was $15.3 million for the first nine months of 2009, compared with
       EBIT of $7.8 million during the same period of 2008.
    -- Gross margin as a percentage of net revenues was 59 percent in the
       third quarter of 2009, compared with 51 percent in the same period of
       2008.
    -- Selling expenses were $1.9 million, less than for the same period in
       2008.

"I'm pleased with our strong third-quarter results," said Dr. Zhong Yi Liu, chairman and chief executive officer. "By slowing down our buildup of new manufacturing facility in Inner Mongolia, we have set our priority in improving our operational efficiency in Beijing by preparing for moving the separated operation units into one single location. We will maintain our focus on improving operation efficiency and maintaining client relationships, and believe we will finish the year well-positioned to enter 2010."

Outlook


'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
2. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
3. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
4. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
5. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
7. Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
8. BioMarin Acquires Huxley Pharmaceuticals, Inc.
9. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
10. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
11. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
(Date:11/21/2014)... 20, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced today that it ... support a strong launch of Edwards Lifesciences Foundation,s new ... improve the global communities where its employees live and ... giving will exceed $8 million, including more than $7 ...
(Date:11/21/2014)... Nov. 20, 2014  RedRick Technologies, a provider ... reading room environment guidance, has helped the new ... reading room, which may also serve as a ... Medicine. "In line with the ... of Radiology,s Imaging 3.0 ™ initiative, the ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3
... Holdings Inc. (OTC Bulletin Board: CGNH ) ... Canadian Intellectual Property Office that its patent application for ... the QL Care™ Analyzer, has been granted. Patents covering ... the European Union and Japan. A patent application for ...
... NEW YORK, Feb. 22, 2011 Reportlinker.com announces ... in its catalogue: Global Gelatin ... This report analyzes the worldwide markets for ... End use segments: Food & Beverage, Pharmaceutical, Photographic ...
Cached Medicine Technology:CardioGenics Granted Patent for 'Core Technology' of its QL Care™ Analyzer 2
(Date:11/23/2014)... (PRWEB) November 23, 2014 This ... such as its significance, programs and manufacturing technological ... Chinese suppliers major market gamers in information. In ... item specifications, prospective, manufacturing value, and 2009-2014 market ... the evaluation symbolizes the globally and Chinese suppliers ...
(Date:11/23/2014)... Asher Milgrom, is a celebrity ... was recently featured on International Business Times. ... CEO of American Medical Aesthetics & Wellness, also known ... full scholarship to attend an M.D./Ph.D program at University ... University of Chicago, where his field of study was ...
(Date:11/23/2014)... , the world’s leader in bamboo flooring, has recently released ... Now, the business is announcing big discounts on these new ... until Dec. 20, 2014. , The new click strand woven ... makes it very easy to maintain. As one of the ... its website the best shopping platform for people who are ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress company, has ... Customers can buy new dresses at its online shop ... website. , As a matter of fact, PrettyTailor specializes ... provides four types of wedding outfits, including bridesmaid dresses, ... It also provides a variety of occasion dresses, such ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
Breaking Medicine News(10 mins):Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2
... RIVER EDGE, N.J., July 2 Nephros, Inc. ... marketing filtration products for therapeutic applications, infection control, and water ... the U.S. FDA to market its Dual Stage Ultrafilters (DSU) ... , , On July 1, 2009, Nephros received approval ...
... YORK, July 2 As we prepare for hotter, humid weeks ... of the country, older adults are at higher risk of health ... from the sweltering heat. About 200 Americans die of health ... them are 50 or older. Due to some of the ...
... The partners of Research4Life announced today at the World Conference ... has demonstrated a dramatic rise in research output by scientists ... in published research before (1996 2002) and after (2002 ... has revealed a 194% or 6.4-fold increase in articles published ...
... of the International Diabetes Federation (IDF) is now open. ... 18-22, 2009 at Palais des Congrs de Montral (Montral ... world,s largest medical conferences, the 20th World Diabetes Congress ... level speakers and more than 200 national diabetes associations ...
... BROOK, Ill., July 2 Thirty-five years ago, the ... to provide a "home away from home" for families ... House Charities(R) (RMHC(R)) kick-off an anniversary celebration to commemorate ... children and families in need worldwide. , , ...
... SAN and NYSE: SNY ) announced today that ... (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or ... to help improve current management of their disease. Multaq(R) is ... shown a clinical benefit to reduce cardiovascular hospitalization in patients ...
Cached Medicine News:Health News:Nephros Receives 510k Approval for Dual Stage Ultrafilters 2Health News:Nephros Receives 510k Approval for Dual Stage Ultrafilters 3Health News:Extreme Heat Causes Major Health Problems for Older Adults 2Health News:Research output in developing countries reveals 194 percent increase in five years 2Health News:Research output in developing countries reveals 194 percent increase in five years 3Health News:Ronald McDonald House Charities(R) (RMHC(R)) and McDonald's(R) Seek Inspiring Stories Through New 'Share.Give.Hope.' Campaign 2Health News:Ronald McDonald House Charities(R) (RMHC(R)) and McDonald's(R) Seek Inspiring Stories Through New 'Share.Give.Hope.' Campaign 3Health News:FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter 2Health News:FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter 3Health News:FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter 4Health News:FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter 5Health News:FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter 6Health News:FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter 7
... The ImmunoDOT Borrelia (Lyme) ... (EIA) dot-blot test for the ... Both,species specific (anti-P39) and related ... and IgA) are detected in ...
... are qualitative enzyme immunoassays (EIA) for the ... or IgM, respectively) in serum. Equivocal or ... supplemented with a standardized western blot procedure. ... support a clinical diagnosis of B. burgdorferi ...
... combining microwell EIA and western blot advantages. ... a clinically meaningful cutoff is applied to ... same reagent system used in most western ... Auto 4 detecting the four common extractable ...
... Antibody (IgM) Test is an ... quantitative detection of antibodies to ... is used as an aid ... thrombosis in individuals with systemic ...
Medicine Products: